SARS-CoV-2 infection affects multiple immune mechanisms and leads to severe COVID-19 and death, in part related to infection-induced or pre-existing autoantibodies. Here, we describe severe COVID-19 to associate with autoantibodies against interleukin-1 receptor antagonist (IL-1Ra) and progranulin (PGRN), endogenous antagonists of IL-1 and TNF signaling, respectively. These autoantibodies coincide with hyperphosphorylation of IL-1Ra (Thr111) or PGRN (Ser81), form immune complexes independent of phosphorylation, reduce antigen plasma levels, and permit enhanced IL-1 and TNF signaling. Using phage-display selected Fabs specific for hyperphosphorylated isoforms, we track phospho-antigens and autoantibodies in a German national pandemic network cohort. Most seropositive patients show both autoantibodies. Levels peak at baseline and decline over 12 months, with phospho-antigens decreasing before autoantibodies. Seropositivity associates with hyperinflammation and cytokine profiles. Importantly, signaling by key inflammatory cytokines induce IL-1Ra and PGRN hyperphosphorylation in healthy monocytes, but require up to 1000-fold higher doses than in monocytes from previously seropositive severe COVID-19 survivors.
- Thurner, L.
- Fadle, N.
- Thurner, B.
- Kos, I. A.
- Bewarder, M.
- Regitz, E.
- Bette, B.
- Fischer, Y.
- Lesan, V.
- Rixecker, T.
- Hoffmann, M. C.
- Preuss, K. D.
- Schormann, C.
- Kaddu-Mulindwa, D.
- Roemer, K.
- Cetin, O.
- Mang, S.
- Becker, A.
- Seiler, F.
- Herr, C.
- Lensch, C.
- Lehmann, J.
- Thiel-Bodenstaff, A.
- Link, A.
- Werner, C.
- Wuchter, P.
- Korper, S.
- Pfuhl, T.
- Lohse, S.
- Rissland, J.
- Thieser, K.
- Pilch, J.
- Papan, C.
- Roth, S.
- Vehreschild, J. J.
- Scherer, M.
- Brohl, I.
- Wagner, P.
- Witzenrath, M.
- Thibeault, C.
- Haack, I. A.
- Mitrov, L.
- Putz, S. M.
- Reese, J. P.
- Krawczak, M.
- Hamelmann, E.
- Kopfnagel, V.
- Fiedler, K.
- Geisler, R.
- Valentin, H.
- Stahl, D.
- Hanss, S.
- Ameling, S.
- Volker, U.
- Hansch, S.
- Dorr, M.
- Blaschke, S.
- Braunsteiner, J.
- Dahl, E.
- Pape, D.
- Petersmann, A.
- Stilgenbauer, S.
- Bloos, F.
- Schrezenmeier, H.
- Langer, F.
- Gabelein, G.
- Friesenhahn-Ochs, B.
- Pfeifer, J.
- Bauer, M.
- Becker, S. L.
- Neumann, F.
- Bohm, M.
- Anton, G.
- Kuenne, C.
- Pullamsetti, S. S.
- Looso, M.
- Bals, R.
- Smola, S.
- Meybohm, P.
- Krawczyk, M.
- Lepper, P. M.
- Kessel, C.
Keywords
- Humans
- *COVID-19/immunology/virology
- Phosphorylation
- *Interleukin 1 Receptor Antagonist Protein/immunology
- *Autoantibodies/immunology/blood
- SARS-CoV-2/immunology
- Female
- Inflammation/immunology
- *Progranulins/immunology
- Male
- Protein Isoforms/immunology
- Interleukin-1/metabolism
- Middle Aged
- Signal Transduction
- Aged
- Tumor Necrosis Factor-alpha/metabolism
- Monocytes/immunology/metabolism
- Adult